Skip to search.
 FTSE 100 Down 1.50%

More On 6MK.DE

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Merck & Co. Inc. (6MK.DE)

-XETRA Ticker: 33Y105/ISIN: US58933Y1055
51.34 Down 0.67(1.29%) 30 Jun 16:02
Add to Portfolio
Prev Close:51.34
Open:51.56
Bid:50.98
Ask:51.05
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:50.95 - 51.65
52wk Range:40.52 - 56.18
Volume:1,047
Avg Vol (3m):1,698
Market Cap:145.05b
P/E (ttm):13.34
EPS (ttm):3.85
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.50
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infec... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback